Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
about
sameAs
Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesisEpigenetics of Peripheral B-Cell Differentiation and the Antibody ResponseHepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells.Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutationFollicular lymphoma: still Six characters in search of an author?Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component.E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response.The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.Msh6 protects mature B cells from lymphoma by preserving genomic stability.Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90.Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphomaRichter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.Absence of immunoglobulin class switch in primary lymphomas of the central nervous system.HCV infection and B-cell lymphomagenesisFollicular lymphoma: too many reminders for a memory B cell.Splice variants of activation induced deaminase (AID) do not affect the efficiency of class switch recombination in murine CH12F3 cells.Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.Novel molecular diagnostic and therapeutic targets in chronic lymphocytic leukaemia.cDNA-library testing identifies transforming genes cooperating with c-myc in mouse pre-B cells.TLR-mediated B cell defects and IFN-α in common variable immunodeficiencyThe BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in FaslAlternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells.Epigenetics of the antibody responseB cell-specific deficiencies in mTOR limit humoral immune responses.Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development.Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis.Hairy cell leukaemia: biological and clinical overview from immunogenetic insights.Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis.Hepatitis C virus cryoglobulinemia and non-hodgkin lymphomaPathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.Epigenetic function of activation-induced cytidine deaminase and its link to lymphomagenesisFunctions and Malfunctions of Mammalian DNA-Cytosine DeaminasesAPOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.Targeting activation-induced cytidine deaminase overcomes tumor evasion of immunotherapy by CTLs.Decoupling of normal CD40/interleukin-4 immunoglobulin heavy chain switch signal leads to genomic instability in SGH-MM5 and RPMI 8226 multiple myeloma cell lines.Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL.
P2860
Q24677146-C83AE4FD-1F94-4501-AD81-B61D61D44049Q26772330-479FBFFE-8571-4E2B-914C-E66E6708B696Q27469843-14BC2234-3A57-48B0-A5AF-3A15DFB13A64Q28260230-7FD2875E-CE64-431F-B0C3-074E2B8C9DF1Q33927978-8AA975E5-C660-489E-948B-E4E68E35B4BBQ34044904-F687FE2E-FCC3-4746-BB3B-F529253F03B4Q34134744-9DE991CA-75BE-41EC-9DD6-04A718D185ACQ34195827-C0A63179-BD3C-4A7F-BDD8-BB6264DD84F2Q34254602-6491EB41-D08E-4714-8BA2-07C530B9DF0CQ34340626-648527AB-CB12-41A9-846B-8810577DB727Q34341934-44F86AD7-E6FE-4F38-B537-6247B78147B2Q34502653-24D90294-8FA1-40B1-9209-63702982D9C5Q35083859-A4D7C846-A58C-4A27-A1AB-AFC9B72FF1FDQ35119527-ABB77251-0479-4A07-BC2A-193029950E4FQ35145414-B412EC79-8AE4-406C-BA1F-AC3E3C593726Q35585086-07C89253-4007-433B-9E14-0736709A8112Q35616311-24D66A18-B71D-4B96-9A3C-081E69382DA3Q35849088-9527EF3A-71C0-4E49-8CFC-BFCBBE93ABE6Q35854960-FC4E2F25-2D22-4CC3-A8F4-1A600E43BBB8Q36107429-6083752C-C58E-4F18-B13A-47CABC91F140Q36190388-FA069313-4EF9-4098-9B5F-7B4707AEDA15Q36321299-69254C5A-AC2A-42CD-B820-AA0F48C0FCA5Q36399625-A63E58EE-A8D7-48DB-807C-8C642208E3FFQ37001985-1B160C57-C328-4759-AFC8-E471C05787A3Q37097751-CC1A43AD-5334-4A11-BFFD-C718DA36BD0CQ37532105-BAF3F541-95BB-4C04-A46F-5639213750ABQ37533750-F12427BE-68BF-491E-A308-22EEBE40A8F4Q37553676-99756ECB-E3D7-4BF6-A1DF-EA7D77B20733Q37816419-8367BDA4-7646-4529-BEB1-FA2DE883B96FQ37889776-1A28782E-0ABC-4348-AA2A-80E49A314811Q37999121-921F13B2-53B2-4265-9DD9-EBC7F2F8A74EQ38003148-6F7C70F3-71F3-4ED5-AAEB-7457807ED2A0Q38030534-70894392-A44D-457E-A7F3-209EEEEF492CQ38310252-F045C911-73E5-4064-9676-59ED34A9EA35Q38943944-755517B2-6E20-4874-99AF-C9770F0EA893Q39245074-F5383BBE-4D64-45AD-942F-9C9EDFF75598Q39713047-40BFCFB4-714B-4A9A-84AD-C28E0CBAFDB3Q40321768-E4658EEB-1F42-46C0-AD4E-8A7243F36A73Q40478235-A6FA41DE-8F96-47AA-BB0F-18018599D11CQ40584407-0CFC8E59-1CE7-433C-82D4-46A9AC7E59CF
P2860
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@ast
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@en
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@nl
type
label
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@ast
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@en
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@nl
prefLabel
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@ast
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@en
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@nl
P2093
P1433
P1476
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
@en
P2093
Antje Philipsen
Brian E Castle
Jobst Greeve
Kenneth B Marcu
Klaus Heidorn
Kristina Krause
Reza Parwaresch
Wolfram Klapper
P304
P356
10.1182/BLOOD-2002-08-2424
P407
P577
2003-05-01T00:00:00Z